“Molecular Docking Study For Adenosine Monophosphate-Activated Protein Kinase Agonist From Syzygium Cumini For Treatment Of Diabetes Mellitus-Type 2”. Journal of Pharmaceutical Negative Results (January 1, 2023): 1078–1085. Accessed June 6, 2026. https://www.pnrjournal.com/index.php/home/article/view/6925.